Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

IPCA LABS vs ZYDUS LIFESCIENCES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    IPCA LABS ZYDUS LIFESCIENCES IPCA LABS/
ZYDUS LIFESCIENCES
 
P/E (TTM) x 51.8 34.5 150.0% View Chart
P/BV x 5.4 5.8 92.5% View Chart
Dividend Yield % 0.3 0.6 54.5%  

Financials

 IPCA LABS   ZYDUS LIFESCIENCES
EQUITY SHARE DATA
    IPCA LABS
Mar-23
ZYDUS LIFESCIENCES
Mar-23
IPCA LABS/
ZYDUS LIFESCIENCES
5-Yr Chart
Click to enlarge
High Rs1,062495 214.5%   
Low Rs768319 240.5%   
Sales per share (Unadj.) Rs243.0170.3 142.7%  
Earnings per share (Unadj.) Rs19.419.8 98.0%  
Cash flow per share (Unadj.) Rs29.726.9 110.3%  
Dividends per share (Unadj.) Rs4.006.00 66.7%  
Avg Dividend yield %0.41.5 29.7%  
Book value per share (Unadj.) Rs230.3173.0 133.1%  
Shares outstanding (eoy) m253.701,012.20 25.1%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.82.4 157.5%   
Avg P/E ratio x47.220.6 229.2%  
P/CF ratio (eoy) x30.815.1 203.7%  
Price / Book Value ratio x4.02.4 168.9%  
Dividend payout %20.630.3 68.0%   
Avg Mkt Cap Rs m232,120412,144 56.3%   
No. of employees `000NANA-   
Total wages/salary Rs m12,87624,564 52.4%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m61,642172,374 35.8%  
Other income Rs m1,5184,746 32.0%   
Total revenues Rs m63,160177,120 35.7%   
Gross profit Rs m9,03329,677 30.4%  
Depreciation Rs m2,6167,227 36.2%   
Interest Rs m4821,299 37.1%   
Profit before tax Rs m7,45325,897 28.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,5345,878 43.1%   
Profit after tax Rs m4,91920,019 24.6%  
Gross profit margin %14.717.2 85.1%  
Effective tax rate %34.022.7 149.8%   
Net profit margin %8.011.6 68.7%  
BALANCE SHEET DATA
Current assets Rs m51,893100,082 51.9%   
Current liabilities Rs m18,05855,267 32.7%   
Net working cap to sales %54.926.0 211.1%  
Current ratio x2.91.8 158.7%  
Inventory Days Days5150 101.8%  
Debtors Days Days694 6.3%  
Net fixed assets Rs m34,336144,776 23.7%   
Share capital Rs m2541,012 25.1%   
"Free" reserves Rs m58,167174,146 33.4%   
Net worth Rs m58,420175,158 33.4%   
Long term debt Rs m6,5180-   
Total assets Rs m86,229244,940 35.2%  
Interest coverage x16.520.9 78.6%   
Debt to equity ratio x0.10-  
Sales to assets ratio x0.70.7 101.6%   
Return on assets %6.38.7 72.0%  
Return on equity %8.411.4 73.7%  
Return on capital %12.215.5 78.7%  
Exports to sales %42.939.2 109.4%   
Imports to sales %13.311.9 111.3%   
Exports (fob) Rs m26,43467,577 39.1%   
Imports (cif) Rs m8,17820,544 39.8%   
Fx inflow Rs m26,43467,577 39.1%   
Fx outflow Rs m8,17820,544 39.8%   
Net fx Rs m18,25747,033 38.8%   
CASH FLOW
From Operations Rs m8,05826,888 30.0%  
From Investments Rs m-7,25011,712 -61.9%  
From Financial Activity Rs m5,072-44,004 -11.5%  
Net Cashflow Rs m5,881-5,338 -110.2%  

Share Holding

Indian Promoters % 46.3 75.0 61.7%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 44.8 18.0 248.4%  
FIIs % 10.3 5.0 205.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 53.7 25.0 214.7%  
Shareholders   82,809 306,495 27.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare IPCA LABS With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    MANKIND PHARMA    


More on IPCA Labs vs Cadila Healthcare

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

IPCA Labs vs Cadila Healthcare Share Price Performance

Period IPCA Labs Cadila Healthcare S&P BSE HEALTHCARE
1-Day 3.49% 1.42% 1.18%
1-Month 4.42% 8.68% -0.75%
1-Year 56.71% 109.28% 61.82%
3-Year CAGR 9.51% 32.67% 18.16%
5-Year CAGR 20.92% 24.73% 19.79%

* Compound Annual Growth Rate

Here are more details on the IPCA Labs share price and the Cadila Healthcare share price.

Moving on to shareholding structures...

The promoters of IPCA Labs hold a 46.3% stake in the company. In case of Cadila Healthcare the stake stands at 75.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IPCA Labs and the shareholding pattern of Cadila Healthcare.

Finally, a word on dividends...

In the most recent financial year, IPCA Labs paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 20.6%.

Cadila Healthcare paid Rs 6.0, and its dividend payout ratio stood at 30.3%.

You may visit here to review the dividend history of IPCA Labs, and the dividend history of Cadila Healthcare.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.